Lee, H. J. Et Al. 2024. Phase 1 study of AYP-101 (soybean phosphatidylcholine): safety, pharmacokinetics, and lipid profile effects for reducing submental fat. LIPIDS IN HEALTH AND DISEASE , vol.23, no.1 .

Lee, H. J., Jiang, X., Abd El-Aty, A. M. A., Jeong, J. H., & Chung, J., (2024). Phase 1 study of AYP-101 (soybean phosphatidylcholine): safety, pharmacokinetics, and lipid profile effects for reducing submental fat. LIPIDS IN HEALTH AND DISEASE , vol.23, no.1.

Lee, Hyun Et Al. "Phase 1 study of AYP-101 (soybean phosphatidylcholine): safety, pharmacokinetics, and lipid profile effects for reducing submental fat," LIPIDS IN HEALTH AND DISEASE , vol.23, no.1, 2024

Lee, Hyun J. Et Al. "Phase 1 study of AYP-101 (soybean phosphatidylcholine): safety, pharmacokinetics, and lipid profile effects for reducing submental fat." LIPIDS IN HEALTH AND DISEASE , vol.23, no.1, 2024

Lee, H. J. Et Al. (2024) . "Phase 1 study of AYP-101 (soybean phosphatidylcholine): safety, pharmacokinetics, and lipid profile effects for reducing submental fat." LIPIDS IN HEALTH AND DISEASE , vol.23, no.1.

@article{article, author={Hyun Joon Lee Et Al. }, title={Phase 1 study of AYP-101 (soybean phosphatidylcholine): safety, pharmacokinetics, and lipid profile effects for reducing submental fat}, journal={LIPIDS IN HEALTH AND DISEASE}, year=2024}